Protocol for fever-range whole-body hyperthermia (WBH) in mice to study febrile effect on T-cell adhesion and migration

por Lin, ChangDong, Liu, ZhaoYuan, Li, Yue, Chen, JianFeng
Publicado 2021

Multicopy Chromosome Integration and Deletion of Negative Global Regulators Significantly Increased the Heterologous Production of Aborycin in Streptomyces coelicolor

por Li, Jia-Yi, Liang, Jun-Yu, Liu, Zhao-Yuan, Yi, Yue-Zhao, Zhao, Jing, Huang, Zhi-Yong, Chen, Jun
Publicado 2023

Identification and characterization of a monoclonal antibody blocking the SARS-CoV-2 spike protein–ACE2 interaction

por Yuan, MengYa, Wan, YaoYing, Liu, Cui, Li, Yue, Liu, ZhaoYuan, Lin, ChangDong, Chen, JianFeng
Publicado 2021

Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction

por Zheng, Yun-zhe, Liu, Zhao-yuan, Li, Yue, Lv, Xiao-ying, Wu, Yi, Huang, Meng-wen, Pan, Xing-chao, Chen, Jian-feng, Lin, Chang-dong
Publicado 2023

Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

por Lin, ChangDong, Li, Yue, Zhang, YueBin, Liu, ZhaoYuan, Mu, Xia, Gu, Chenjian, Liu, Jing, Li, Yutang, Li, GuoHui, Chen, JianFeng
Publicado 2021

Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

por Lin, ChangDong, Li, Yue, Zhang, YueBin, Liu, ZhaoYuan, Mu, Xia, Gu, Chenjian, Liu, Jing, Li, Yutang, Li, GuoHui, Chen, JianFeng
Publicado 2021

Distinct chemokines selectively induce HIV-1 gp120-integrin α4β7 binding via triggering conformer-specific activation of α4β7

por Wang, Shu, Lin, ChangDong, Li, Yue, Liu, ZhaoYuan, Wang, JunLei, Zhang, YouHua, Yan, ZhanJun, Zhang, YueBin, Li, GuoHui, Chen, JianFeng
Publicado 2021